PSP Targets Prostate Cancer Stem Cells
Author Information
Author(s): Luk Sze-Ue, Lee Terence Kin-Wah, Liu Ji, Lee Davy Tak-Wing, Chiu Yung-Tuen, Ma Stephanie, Ng Irene Oi-Lin, Wong Yong-Chuan, Chan Franky Leung, Ling Ming-Tat
Primary Institution: Australian Prostate Cancer Research Centre-Queensland and Institute of Health and Biomedical Innovation, Queensland University of Technology
Hypothesis
Can PSP effectively target prostate cancer stem cells and inhibit tumor formation?
Conclusion
PSP treatment can completely inhibit prostate tumor formation in a transgenic mouse model.
Supporting Evidence
- PSP treatment led to down-regulation of CSC markers CD133 and CD44 in prostate cancer cells.
- PSP completely inhibited tumor formation in transgenic mice fed with PSP.
- PSP suppressed the ability of prostate cancer cells to form prostaspheres.
Takeaway
A mushroom extract called PSP can help stop prostate cancer from growing by targeting the special cells that cause the cancer.
Methodology
The study involved treating prostate cancer cell lines with PSP and observing effects on stem cell markers and tumor formation in mice.
Potential Biases
Potential bias in the selection of treatment dosages and duration.
Limitations
The study did not assess the long-term effects of PSP treatment beyond the experimental period.
Participant Demographics
Transgenic mice (TgMAP) used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website